PIN1 and cancer: The oncogenic properties associated with dysregulation of Pin1 activities identify the isomerase as an attractive target for the development of new therapeutic approaches for cancer treatment (Zhou and Lu, 2016; Wu et al., 2022; Chuang et al., 2021).